Xenetic Biosciences, Inc.XBIONASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank74
3Y CAGR-28.7%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
-28.7%/yr
Quarterly compound
Percentile
P74
Within normal range
vs 3Y Ago
0.4x
Contraction
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 24.80% |
| Q2 2025 | 23.13% |
| Q1 2025 | 14.26% |
| Q4 2024 | -120.06% |
| Q3 2024 | 62.65% |
| Q2 2024 | -5.44% |
| Q1 2024 | -1.02% |
| Q4 2023 | -9.50% |
| Q3 2023 | 4.30% |
| Q2 2023 | -30.92% |
| Q1 2023 | 41.46% |
| Q4 2022 | -84.40% |
| Q3 2022 | 68.45% |
| Q2 2022 | -65.90% |
| Q1 2022 | 13.57% |
| Q4 2021 | -36.19% |
| Q3 2021 | -22.02% |
| Q2 2021 | 17.64% |
| Q1 2021 | -12.22% |
| Q4 2020 | 88.39% |
| Q3 2020 | -969.20% |
| Q2 2020 | 20.18% |
| Q1 2020 | 0.33% |
| Q4 2019 | 86.20% |
| Q3 2019 | -549.10% |
| Q2 2019 | -3.85% |
| Q1 2019 | 19.05% |
| Q4 2018 | 9.66% |
| Q3 2018 | 8.96% |
| Q2 2018 | -9.04% |
| Q1 2018 | -141.26% |
| Q4 2017 | 297.76% |
| Q3 2017 | 22.83% |
| Q2 2017 | -1.67% |
| Q1 2017 | -4331.94% |
| Q4 2016 | 97.14% |
| Q3 2016 | 94.80% |
| Q2 2016 | -2236.45% |
| Q1 2016 | 31.21% |
| Q4 2015 | 29.18% |